J&J | JNJ - Efectivo Y Equivalentes

Precio De Mercado
227.35
Cambio Diario
-0.44 -0.19%
Mensual
-6.24%
Anual
45.45%
Q2 Expectativa
222.63




Efectivo Y Equivalentes Cambio Fecha
AbbVie USD 5.23B 400M 2025-12
Abbott USD 6.8B 1.72B 2026-03
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 5.71B 2.43B 2025-12
Baxter International USD 1.97B 240M 2025-12
Bayer EUR 5.9B 1.34B 2025-09
Becton, Dickinson and Co. USD 740M 99M 2025-12
Biogen USD 3.01B 854.3M 2025-12
Boston Scientific USD 1.96B 690M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
CONMED USD 40.82M 1.89M 2025-12
Cooper Companies USD 110.6M 14.3M 2025-09
Dexcom USD 917.7M 918M 2025-12
Edwards Lifesciences USD 2.4B 538M 2026-03
Eli Lilly USD 7.27B 2.52B 2025-12
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.15B 146M 2025-12
Globus Medical USD 526.16M 154.39M 2025-12
Insulet USD 716.1M 41.3M 2025-12
Integra LifeSciences USD 235.05M 2.86M 2025-12
Intuitive Surgical USD 7.98B 1.05B 2026-03
J&J USD 21.69B 1.98B 2026-03
Medtronic USD 1.15B 135M 2025-12
Merck USD 18.17B 10.16B 2025-09
Merit Medical Systems USD 446.4M 53.95M 2025-12
Novartis USD 11.44B 1.88B 2025-12
Pfizer USD 1.34B 295M 2025-09
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Stryker USD 4.01B 755M 2025-12
Tandem Diabetes Care USD 90.63M 1.31M 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12
Zoetis USD 2.08B 649M 2025-09